Arbilux SA
Arbilux reported total assets of 192,841 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Arbilux shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -18 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Arbilux's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 15 May 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Arbilux's financial analysis
- Solvency-28.7%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Arbilux
Arbilux's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0419.806.595
- VAT number
- BE0419806595
- Peppol
- Registered · 0208:0419806595 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Sep 1979
- Registered office
- 6940 Durbuy
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Arbilux (SA) has been based in Durbuy since 1979, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 19,609 € and equity of −55,367 €; its revenue is not published. Its solvency stands at -28.7%, below the median of its sector (43.9%).
Companies similar to Arbilux
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Belgomed Wholesale of pharmaceutical and medical goods Hasselt · balance sheet 184,456 €
Frequently asked questions about Arbilux
What is the revenue of Arbilux?
Arbilux files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Arbilux?
In Belgium, the VAT number is the company number prefixed with BE: BE0419806595 for Arbilux, if the company is VAT-registered. Its company number (CBE) is 0419.806.595.
Where is the registered office of Arbilux?
According to the CBE register, the registered office of Arbilux is in 6940 Durbuy.
What is the equity of Arbilux?
At the close of the 2025 financial year, the equity of Arbilux amounts to -55,367 €, a solvency of -28.7% of total assets.
Who manages Arbilux?
The register lists 2 active mandates at Arbilux. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Arbilux
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →